Rare giant dural chondroma of the convexity in an adolescent: a case report and literature review

Background Intracranial chondroma (ICD) is an exceptionally rare benign neoplasm that typically arises at the skull base. Herein, we report an exceedingly uncommon case of giant ICD originating from the dural cerebral convexity, along with a review of the relevant literature. Case presentation A 15-year-old female was admitted to hospital for a left ankle sprain with unremarkable initial neurological findings. Occasional mild dizziness developed during inpatient management of the ankle injury, prompting cranial computed tomography (CT) and magnetic resonance imaging (MRI) that incidentally detected a massive mass in the right frontoparietal region. Preoperative imaging findings were initially suggestive of a solitary fibrous tumor (SFT). Definitive histopathological examination revealed a tumor composed of nodular hyaline cartilage, with chondrocytes residing within the cartilage lacunae at low cellular density. The cartilaginous cells exhibited mononuclear morphology containing small hyperchromatic nuclei and abundant cytoplasm, while the intercellular spaces were occupied by a grayish-blue cartilage matrix. Immunohistochemically, tumor cells were diffusely positive for S-100 and vimentin, with a Ki-67 proliferation index of <1%, and negative for EMA, Pan-CK, Brachyury, and CD34. Molecular analysis identified a somatic mutation in the isocitrate dehydrogenase 1 ( IDH1 ) gene (p.R132C). Combined clinicopathological and molecular findings support a pathological diagnosis of convexity dural chondroma (CDC). The patient has remained recurrence-free for three years after gross-total surgical resection of the tumor. Conclusion Giant CDCs present with subtle clinical symptoms and are frequently discovered incidentally on neuroimaging, where they may be misdiagnosed as SFTs and meningiomas. Definitive diagnosis relies on histopathological examination, with mandatory differentiation from chondrosarcoma, meningiomas with chondroplasia, and chordoma. Complete surgical resection achieves favorable tumor control; the patient remained recurrence-free at the three-year follow-up in the present case.

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fmed.2026.2000428
Primary Topic
Bone Tumor Diagnosis and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rare giant dural chondroma of the convexity in an adolescent: a case report and literature review

Yi Wang, Ya Jiang, Wenmang Xu, Xingyan Chen et al.
Frontiers in Medicine
Bone Tumor Diagnosis and Treatments
article

Rare giant dural chondroma of the convexity in an adolescent: a case report and literature review

Yi Wang, Ya Jiang, Wenmang Xu, Xingyan Chen, Ziran Gao
article en

Abstract

Background Intracranial chondroma (ICD) is an exceptionally rare benign neoplasm that typically arises at the skull base. Herein, we report an exceedingly uncommon case of giant ICD originating from the dural cerebral convexity, along with a review of the relevant literature. Case presentation A 15-year-old female was admitted to hospital for a left ankle sprain with unremarkable initial neurological findings. Occasional mild dizziness developed during inpatient management of the ankle injury, prompting cranial computed tomography (CT) and magnetic resonance imaging (MRI) that incidentally detected a massive mass in the right frontoparietal region. Preoperative imaging findings were initially suggestive of a solitary fibrous tumor (SFT). Definitive histopathological examination revealed a tumor composed of nodular hyaline cartilage, with chondrocytes residing within the cartilage lacunae at low cellular density. The cartilaginous cells exhibited mononuclear morphology containing small hyperchromatic nuclei and abundant cytoplasm, while the intercellular spaces were occupied by a grayish-blue cartilage matrix. Immunohistochemically, tumor cells were diffusely positive for S-100 and vimentin, with a Ki-67 proliferation index of <1%, and negative for EMA, Pan-CK, Brachyury, and CD34. Molecular analysis identified a somatic mutation in the isocitrate dehydrogenase 1 ( IDH1 ) gene (p.R132C). Combined clinicopathological and molecular findings support a pathological diagnosis of convexity dural chondroma (CDC). The patient has remained recurrence-free for three years after gross-total surgical resection of the tumor. Conclusion Giant CDCs present with subtle clinical symptoms and are frequently discovered incidentally on neuroimaging, where they may be misdiagnosed as SFTs and meningiomas. Definitive diagnosis relies on histopathological examination, with mandatory differentiation from chondrosarcoma, meningiomas with chondroplasia, and chordoma. Complete surgical resection achieves favorable tumor control; the patient remained recurrence-free at the three-year follow-up in the present case.

Frontiers in MedicineVol. 13
Second People's Hospital of Yunnan Province (CN), Chinese People's Liberation Army (CN), Yunnan University of Traditional Chinese Medicine (CN)
Good health and well-being
Bone Tumor Diagnosis and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon